We are live on ! Find out more
ADPT icon

Adaptive Biotechnologies
ADPT

209 hedge funds and large institutions have $1.08B invested in Adaptive Biotechnologies in 2022 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 88 increasing their positions, 58 reducing their positions, and 40 closing their positions.

New
Increased
Maintained
Reduced
Closed

289% more call options, than puts

Call options by funds: $1.62M | Put options by funds: $417K

52% more repeat investments, than reductions

Existing positions increased: 88 | Existing positions reduced: 58

5.66% more ownership

Funds ownership: 88.71% → 94.37% (+5.7%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

5% less funds holding

Funds holding: 221 → 209 (-12)

25% less first-time investments, than exits

New positions opened: 30 | Existing positions closed: 40

38% less capital invested

Capital invested by funds: $1.74B → $1.08B (-$657M)

Holders
209
Holders Change
-12
Holders Change %
-5.43%
% of All Funds
3.52%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
30
Increased
88
Reduced
58
Closed
40
Calls
$1.62M
Puts
$417K
Net Calls
+$1.21M
Net Calls Change
+$2.11M

Top Buyers

1
BWLSA
Blue Water Life Science Advisors
California
+$27.4M
2
BlackRock
BlackRock
New York
+$26.9M
3
AIM
ARK Investment Management
Florida
+$9.35M
4
Federated Hermes
Federated Hermes
Pennsylvania
+$7.4M
5
Principal Financial Group
Principal Financial Group
Iowa
+$6.02M

Top Sellers

1
Massachusetts Financial Services
Massachusetts Financial Services
Massachusetts
-$17.9M
2
CC
Casdin Capital
New York
-$13.9M
3
TCM
TimesSquare Capital Management
New York
-$10.9M
4
Ameriprise
Ameriprise
Minnesota
-$9M
5
TM
Tiger Management
New York
-$8.18M
Name Holding Trade Value Shares
Change 		Change in
Stake
Viking Global Investors
1
Viking Global Investors
Connecticut
$243M – – –
T. Rowe Price Associates
2
T. Rowe Price Associates
Maryland
$98.6M -$2.04M -232,472 -2%
Vanguard Group
3
Vanguard Group
Pennsylvania
$93.7M +$4.27M +485,540 +4%
MCMC
4
Matrix Capital Management Company
New Hampshire
$93.6M – – –
BlackRock
5
BlackRock
New York
$73M +$26.9M +3,054,607 +51%
AIM
6
ARK Investment Management
Florida
$68.6M +$9.35M +1,063,352 +14%
Sumitomo Mitsui Trust Group
7
Sumitomo Mitsui Trust Group
Japan
$37.4M +$4.28M +486,339 +12%
NAMA
8
Nikko Asset Management Americas
New York
$36.1M +$4.2M +477,621 +12%
BG
9
Bellevue Group
Switzerland
$28.6M +$3.46M +393,762 +13%
BWLSA
10
Blue Water Life Science Advisors
California
$25.2M +$27.4M +3,120,434 New
State Street
11
State Street
Massachusetts
$18.9M +$4.09M +464,913 +25%
Geode Capital Management
12
Geode Capital Management
Massachusetts
$16.4M +$5.42M +615,970 +44%
Federated Hermes
13
Federated Hermes
Pennsylvania
$11.3M +$7.4M +841,334 +151%
Goldman Sachs
14
Goldman Sachs
New York
$10.8M +$1.45M +164,380 +14%
AAP
15
Aristotle Atlantic Partners
Florida
$10.8M +$5.01M +569,856 +75%
EHI
16
Eagle Health Investments
Connecticut
$9.83M +$1.76M +200,000 +20%
Principal Financial Group
17
Principal Financial Group
Iowa
$9.72M +$6.02M +685,171 +133%
Morgan Stanley
18
Morgan Stanley
New York
$9.28M +$5.63M +640,112 +126%
Norges Bank
19
Norges Bank
Norway
$9.11M +$529K +60,206 +6%
Charles Schwab
20
Charles Schwab
California
$8.85M +$2.06M +233,850 +27%
Northern Trust
21
Northern Trust
Illinois
$8.18M +$4.81M +547,304 +118%
SIG
22
Senator Investment Group
New York
$8.09M – – –
Massachusetts Financial Services
23
Massachusetts Financial Services
Massachusetts
$6.82M -$17.9M -2,034,767 -71%
Marshall Wace
24
Marshall Wace
United Kingdom
$5.56M -$2.09M -238,254 -26%
Millennium Management
25
Millennium Management
New York
$5.32M +$598K +68,008 +12%
1
2 3 4 5

ADPT Hedge Fund Activity: Q2 2022 in Review

209 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Adaptive Biotechnologies (ADPT) for Q2 2022, worth a combined $1.08B — down 38% from $1.74B a quarter earlier.

Sellers outnumbered buyers: 40 funds closed out of ADPT and 30 opened new positions — a net loss of 10 holders — while 58 trimmed existing stakes and 88 added.

The largest buyer was Blue Water Life Science Advisors, opening a new position worth an estimated $27.4M. The largest seller was Massachusetts Financial Services, cutting an estimated $17.9M.

  • 209 institutional investors held Adaptive Biotechnologies (ADPT) as of Q2 2022, down from 221 in Q1 2022.
  • Funds reported $1.08B of Adaptive Biotechnologies stock for Q2 2022, down 38% quarter-over-quarter.
  • 30 funds opened new Adaptive Biotechnologies positions in Q2 2022 and 40 closed out, a net change of -10 holders.
  • The largest Adaptive Biotechnologies buyer in Q2 2022 was Blue Water Life Science Advisors, an estimated $27.4M added.
  • The largest Adaptive Biotechnologies seller in Q2 2022 was Massachusetts Financial Services, an estimated $17.9M sold.

Based on aggregated 13F filings for Q2 2022.